02/03/2026
Genomics is transforming health outcomes across Atlantic Canada
From preventing fatal heart disease to accelerating rare disease diagnosis to advancing mental health care - Genome Atlantic's health research is delivering life-changing impact across our region.
Preventing Fatal Heart Disease: Our support helped Memorial University researchers identify the genetic mutation behind the "Newfoundland Curse” - arrhythmogenic right ventricular cardiomyopathy (ARVC). A simple blood test now identifies at-risk individuals, and implantable defibrillators have saved countless lives. The team received the Governor General's Innovation Award in 2018.
Faster Diagnosis, Closer to Home: The All-for-One Rare Diseases initiative ($4.8M) brought clinical genome sequencing to Atlantic Canada, reducing diagnostic wait times from 7-8 years and giving families earlier answers without outsourcing to U.S. labs.
Mental Health Breakthroughs: We're supporting groundbreaking research into the genetic underpinnings of bipolar disorder and serious mental illness, with recent findings showing genetic testing can be nearly as accurate as family history in detecting vulnerability, paving the way for earlier intervention and more effective treatment.
From the heart to the mind, our health research spans the full spectrum of human health, delivering better outcomes for Atlantic Canadians.
Find out how is improving health, the economy & the environment https://bit.ly/3YEaOHW